Literature DB >> 27160588

Symptoms and Needs of Head and Neck Cancer Patients at Diagnosis of Incurability - Prevalences, Clinical Implications, and Feasibility of a Prospective Longitudinal Multicenter Cohort Study.

Bernd Alt-Epping1, Wiebke Seidel, Jeannette Vogt, Anja Mehnert, Michael Thomas, Birgitt van Oorschot, Hendrik Wolff, Henning Schliephake, Martin Canis, Leif H Dröge, Friedemann Nauck, Florian Lordick.   

Abstract

BACKGROUND: Little is known about the physical symptoms and psychosocial burden of patients at the time of diagnosis of an incurable situation, although cancer treatment guidelines demand early assessment and integration of palliative care concepts, beginning from the diagnosis of incurability.
METHODS: Therefore, we initiated a prospective longitudinal multicenter cohort study assessing the symptoms and needs of patients suffering from incurable cancer (various entities), from the time of diagnosing incurability (i.e., before palliative anticancer treatment was initiated) and in 3-monthly intervals thereafter, by using validated self-reporting tools. Here, we focus on patients with head and neck cancer and present preliminary results on symptoms and need prevalences, on clinical implications, and on the feasibility of a methodologically complex assessment procedure in a particularly vulnerable study population.
RESULTS: 22 patients completed the first visit. The Eastern Cooperative Oncology Group (ECOG) performance scores and most physical symptoms and psychosocial items varied between the extremes, from a virtually uncompromised condition to extremely perceived symptoms and needs. If intense face-to-face study support was provided, the study concept proved to be feasible, despite the complexity of assessment, problems in interdisciplinary and patient communication, comorbidities, and early death from complications.
CONCLUSIONS: The striking variability in the perceived symptom and need intensities requires a highly individualized approach. For clinical purposes, a less complex screening procedure would be desirable, in order to enable a routine, early and comprehensive support, including palliative care services.
© 2016 S. Karger GmbH, Freiburg.

Entities:  

Mesh:

Year:  2016        PMID: 27160588     DOI: 10.1159/000445307

Source DB:  PubMed          Journal:  Oncol Res Treat        ISSN: 2296-5270            Impact factor:   2.825


  4 in total

1.  [Anticancer therapy for symptom relief? : A systematic review of clinical trials in oncology].

Authors:  B Alt-Epping; A-L Haas; M Jansky; F Nauck
Journal:  Schmerz       Date:  2018-04       Impact factor: 1.107

2.  Symptom Burden and Palliative Care Needs of Patients with Incurable Cancer at Diagnosis and During the Disease Course.

Authors:  Jeannette Vogt; Franziska Beyer; Jochen Sistermanns; Jonas Kuon; Christoph Kahl; Bernd Alt-Epping; Susanne Stevens; Miriam Ahlborn; Christian George; Andrea Heider; Maria Tienken; Carmen Loquai; Kerstin Stahlhut; Anne Ruellan; Thomas Kubin; Andreas Dietz; Karin Oechsle; Anja Mehnert-Theuerkauf; Birgitt van Oorschot; Michael Thomas; Olaf Ortmann; Christoph Engel; Florian Lordick
Journal:  Oncologist       Date:  2021-03-30

3.  Disease trajectories, place and mode of death in people with head and neck cancer: Findings from the 'Head and Neck 5000' population-based prospective clinical cohort study.

Authors:  Catriona R Mayland; Kate Ingarfield; Simon N Rogers; Paola Dey; Steven Thomas; Andrea Waylen; Sam D Leary; Miranda Pring; Katrina Hurley; Tim Waterboer; Michael Pawlita; Andy R Ness
Journal:  Palliat Med       Date:  2020-02-27       Impact factor: 4.762

Review 4.  The palliative care needs and experiences of people with advanced head and neck cancer: A scoping review.

Authors:  Catriona R Mayland; Qiaoling Marilyn Ho; Hannah C Doughty; Simon N Rogers; Prithvi Peddinti; Praytush Chada; Stephen Mason; Matthew Cooper; Paola Dey
Journal:  Palliat Med       Date:  2020-10-21       Impact factor: 4.762

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.